1. Home
  2. PM vs NVO Comparison

PM vs NVO Comparison

Compare PM & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PM
  • NVO
  • Stock Information
  • Founded
  • PM 1987
  • NVO 1923
  • Country
  • PM United States
  • NVO Denmark
  • Employees
  • PM N/A
  • NVO N/A
  • Industry
  • PM Medicinal Chemicals and Botanical Products
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PM Health Care
  • NVO Health Care
  • Exchange
  • PM Nasdaq
  • NVO Nasdaq
  • Market Cap
  • PM 256.7B
  • NVO 243.4B
  • IPO Year
  • PM N/A
  • NVO N/A
  • Fundamental
  • Price
  • PM $145.76
  • NVO $50.04
  • Analyst Decision
  • PM Strong Buy
  • NVO Buy
  • Analyst Count
  • PM 9
  • NVO 10
  • Target Price
  • PM $195.44
  • NVO $80.40
  • AVG Volume (30 Days)
  • PM 8.3M
  • NVO 10.6M
  • Earning Date
  • PM 10-21-2025
  • NVO 11-05-2025
  • Dividend Yield
  • PM 4.01%
  • NVO 2.40%
  • EPS Growth
  • PM N/A
  • NVO 24.25
  • EPS
  • PM 5.52
  • NVO 3.93
  • Revenue
  • PM $39,992,000,000.00
  • NVO $49,108,936,497.00
  • Revenue This Year
  • PM $11.43
  • NVO $9.58
  • Revenue Next Year
  • PM $8.39
  • NVO $7.39
  • P/E Ratio
  • PM $26.58
  • NVO $13.08
  • Revenue Growth
  • PM 7.45
  • NVO 20.91
  • 52 Week Low
  • PM $116.12
  • NVO $45.05
  • 52 Week High
  • PM $186.69
  • NVO $113.76
  • Technical
  • Relative Strength Index (RSI)
  • PM 32.96
  • NVO 28.27
  • Support Level
  • PM $142.33
  • NVO $52.38
  • Resistance Level
  • PM $159.11
  • NVO $53.55
  • Average True Range (ATR)
  • PM 3.88
  • NVO 0.99
  • MACD
  • PM -0.90
  • NVO -0.60
  • Stochastic Oscillator
  • PM 18.28
  • NVO 5.24

About PM Philip Morris International Inc

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokable products but also gained a toehold in the US to sell its Iqos heated tobacco product.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: